Insiders / Fairmount Funds Management LLC / Activity
Activity — Fairmount Funds Management LLC
11 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Sell | COGT Cogent Biosciences, Inc. Common Stock | $242.62M | -7.0M -55.98% | 5,503,418 3.17% of shares | high |
| Jan 22, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $133.53M | -1.8M -85.42% | 298,647 0.39% of shares | high |
| Jan 22, 2026 | Sell | COGT Cogent Biosciences, Inc. Common Stock | $127.40M | -3.5M -38.87% | 5,503,418 3.17% of shares | high |
| Feb 9, 2026 | Exercise | DMRA Galecto, Inc. Common Stock | $0 | +2.9M | 2,904,000 4.70% of shares | low |
| Feb 9, 2026 | Exercise | DMRA Galecto, Inc. Common Stock | $0 | +5.8M | 5,809,000 9.41% of shares | low |
| Jun 2, 2026 | Grant | CBIO Crescent Biopharma, Inc. Stock Option (Right to Buy) | — | +11K | 11,050 0.03% of shares | low |
| Mar 23, 2026 | Grant | DMRA Galecto, Inc. Stock Option (right to buy) | — | +37K | 37,313 0.06% of shares | low |
| Feb 9, 2026 | Exercise | DMRA Galecto, Inc. Series C Preferred Stock | — | -3K -83.50% | 574 <0.01% of shares | low |
| Feb 9, 2026 | Exercise | DMRA Galecto, Inc. Series C Preferred Stock | — | -6K -83.50% | 1,148 <0.01% of shares | low |
| Mar 31, 2026 | Other | COGT Cogent Biosciences, Inc. Series A Convertible Preferred Stock | — | -28K -41.53% | 39,414 0.02% of shares | low |
| Mar 31, 2026 | Other | COGT Cogent Biosciences, Inc. Common Stock | — | +7.0M +127.19% | 12,503,418 7.21% of shares | low |